Chorioamnionitis: From pathogenesis to treatment

Clinical Microbiology and Infection

Volumn 17, Issue 9, 2011, Pages 1304-1311

  Czikk, M J ^a   McCarthy, F P ^b   Murphy, K E ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Antibiotic therapy; Chorioamnionitis; Intra amniotic infection; PPROM; Prevention

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; AMPICILLIN; ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; AZITHROMYCIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; ERYTHROMYCIN; FERRITIN; FIBRONECTIN; INTERLEUKIN 6; INTERLEUKIN 8; NEUTROPHIL COLLAGENASE; RELAXIN; RIFAMPICIN; THROMBIN ANTITHROMBIN COMPLEX;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ADENOVIRUS; ADVERSE OUTCOME; ADVERSE PREGNANCY OUTCOME; AMNIOCENTESIS; AMNION; AMNION FLUID ANALYSIS; ANTIMICROBIAL THERAPY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BRUCELLA ABORTUS; BRUCELLA CANIS; BRUCELLA MELITENSIS; BRUCELLA SUIS; BRUCELLOSIS; CHLAMYDIA; CHLAMYDIA ABORTUS; CHLAMYDIA TRACHOMATIS; CHLAMYDIACEAE; CHLAMYDIACEAE INFECTION; CHLAMYDIASIS; CHORIOAMNIONITIS; COXIELLA BURNETII; COXIELLA INFECTION; CYTOMEGALOVIRUS; DOMESTIC ANIMAL; DRUG SAFETY; ENTEROVIRUS; EPSTEIN BARR VIRUS; FETUS DEATH; FETUS HEART RATE; FEVER; GARDNERELLA VAGINALIS; GRAM NEGATIVE ANAEROBIC BACTERIA; HIGH RISK INFANT; HUMAN; INFECTION RATE; INTRACELLULAR BACTERIUM; INTRAUTERINE GROWTH RETARDATION; LEUKOCYTE COUNT; LISTERIOSIS; MATERNAL MORBIDITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOPLASMA; MYCOPLASMA HOMINIS; NEISSERIA GONORRHOEAE; NEUTROPHIL CHEMOTAXIS; NEWBORN MORBIDITY; NONHUMAN; PATHOGENESIS; POLYMICROBIAL INFECTION; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; Q FEVER; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SPONTANEOUS ABORTION; STILLBIRTH; TACHYCARDIA; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT OUTCOME; TRICHOMONAS VAGINALIS; UREAPLASMA UREALYTICUM; VAGINAL LAVAGE;

MYCOPLASMA HOMINIS; NEGIBACTERIA; UREAPLASMA UREALYTICUM;

EID: 80051904739     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03574.x     Document Type: Review

References (72)

1. Newton ER. Chorioamnionitis and intraamniotic infection. Clin Obstet Gynecol 1993; 36: 795-808.
2. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000; 342: 1500-1507.
3. Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med 1988; 319: 972-978.
4. Menon R, Taylor RN, Fortunato SJ. Chorioamnionitis-a complex pathophysiologic syndrome. Placenta 2010; 31: 113-120.
5. Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler C. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2003; 6: 435-448.
6. Alexander JM, McIntire DM, Leveno KJ. Chorioamnionitis and the prognosis for term infants. Obstet Gynecol 1999; 94: 274-278.
7. Wu YW, Colford JM Jr. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000; 284: 1417-1424.
8. Yoon BH, Romero R, Kim KS et al. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999; 181: 773-779.
9. Mueller-Heubach E, Rubinstein DN, Schwarz SS. Histologic chorioamnionitis and preterm delivery in different patient populations. Obstet Gynecol 1990; 75: 622-626.
10. Hauth JC, Gilstrap LC 3rd, Hankins GD, Connor KD. Term maternal and neonatal complications of acute chorioamnionitis. Obstet Gynecol 1985; 66: 59-62.
11. Rouse DJ, Landon M, Leveno KJ et al. The maternal-fetal medicine units cesarean registry: chorioamnionitis at term and its duration-relationship to outcomes. Am J Obstet Gynecol 2004; 191: 211-216.
12. Tran TS, Jamulitrat S, Chongsuvivatwong V, Geater A. Risk factors for postcesarean surgical site infection. Obstet Gynecol 2000; 95: 367-371.
13. Newton ER. Preterm labor, preterm premature rupture of membranes, and chorioamnionitis. Clin Perinatol 2005; 32: 571-600.
14. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S. The role of inflammation and infection in preterm birth. Semin Reprod Med 2007; 25: 21-39.
15. Goldman AS, Schmalstieg FC. The pathogenesis of chorioamnionitis. J Pediatr 2008; 153: 3-4.
16. Sperling RS, Newton E, Gibbs RS. Intraamniotic infection in low-birth-weight infants. J Infect Dis 1988; 157: 113-117.
17. Baschat AA, Towbin J, Bowles NE, Harman CR, Weiner CP. Prevalence of viral DNA in amniotic fluid of low-risk pregnancies in the second trimester. J Matern Fetal Neonatal Med 2003; 13: 381-384.
18. Tsekoura EA, Konstantinidou A, Papadopoulou S et al. Adenovirus genome in the placenta: association with histological chorioamnionitis and preterm birth. J Med Virol 2010; 82: 1379-1383.
19. Asemota OA, Nyirjesy P, Fox R, Sobel JD. Candida glabrata complicating in vitro pregnancy: successful management of subsequent pregnancy. Fertil Steril 2011; 95: 803.e1-803.e2.
20. Meizoso T, Rivera T, Fernandez-Acenero MJ, Mestre MJ, Garrido M, Garaulet C. Intrauterine candidiasis: report of four cases. Arch Gynecol Obstet 2008; 278: 173-176.
21. Barth T, Broscheit J, Bussen S, Dietl J. Maternal sepsis and intrauterine fetal death resulting from candida tropicalis chorioamnionitis in a woman with a retained intrauterine contraceptive device. Acta Obstet Gynecol Scand 2002; 81: 981-982.
22. Morgan MA, Pippitt CH, Thurnau GR. Antenatal diagnosis of candida chorioamnionitis. South Med J 1989; 82: 276.
23. Rode ME, Morgan MA, Ruchelli E, Forouzan I. Candida chorioamnionitis after serial therapeutic amniocenteses: a possible association. J Perinatol 2000; 20: 335-337.
24. Engelhart CM, van de Vijver NM, Nienhuis SJ, Hasaart TH. Fetal candida sepsis at midgestation: a case report. Eur J Obstet Gynecol Reprod Biol 1998; 77: 107-109.
25. Fowler P. Methicillin-resistant staphylococcus aureus chorioamnionitis: a rare cause of fetal death in our community. Aust NZ J Obstet Gynaecol 2002; 42: 97-98.
26. Geisler JP, Horlander KM, Hiett AK. Methicillin resistant staphylococcus aureus as a cause of chorioamnionitis. Clin Exp Obstet Gynecol 1998; 25: 119-120.
27. Steel JH, Malatos S, Kennea N et al. Bacteria and inflammatory cells in fetal membranes do not always cause preterm labor. Pediatr Res 2005; 57: 404-411.
28. Romero R, Espinoza J, Kusanovic JP et al. The preterm parturition syndrome. Br J Obstet Gynaecol 2006; 113 (suppl 3): 17-42.
29. Zhou X, Brotman RM, Gajer P et al. Recent advances in understanding the microbiology of the female reproductive tract and the causes of premature birth. Infect Dis Obstet Gynecol 2010; 2010: 737425.
30. Mi Lee S, Romero R, Lee KA et al. The frequency and risk factors of funisitis and histologic chorioamnionitis in pregnant women at term who delivered after the spontaneous onset of labor. J Matern Fetal Neonatal Med 2011; 24: 37-42.
31. Seaward PG, Hannah ME, Myhr TL et al. International multicentre term prelabor rupture of membranes study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term. Am J Obstet Gynecol 1997; 177: 1024-1029.
32. Fahey JO. Clinical management of intra-amniotic infection and chorioamnionitis: a review of the literature. J Midwifery Womens Health 2008; 53: 227-235.
33. Tita AT, Andrews WW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol 2010; 37: 339-354.
34. Smulian JC, Shen-Schwarz S, Vintzileos AM, Lake MF, Ananth CV. Clinical chorioamnionitis and histologic placental inflammation. Obstet Gynecol 1999; 94: 1000-1005.
35. Carroll SG. Preterm prelabour rupture of membranes. Green Top Guideline No. 44. Royal College of Obstetricians and Gynaecologists, 2006 (Minor amendment October 2010).
36. Berger A, Witt A, Haiden N, Kretzer V, Heinze G, Pollak A. Amniotic cavity cultures, blood cultures, and surface swabs in preterm infants-useful tools for the management of early-onset sepsis? J Perinat Med 2004; 32: 446-452.
37. Locksmith GJ, Duff P. Assessment of the value of routine blood cultures in the evaluation and treatment of patients with chorioamnionitis. Infect Dis Obstet Gynecol 1994; 2: 111-114.
38. Buhimschi CS, Sfakianaki AK, Hamar BG et al. A low vaginal 'pool' amniotic fluid glucose measurement is a predictive but not a sensitive marker for infection in women with preterm premature rupture of membranes. Am J Obstet Gynecol 2006; 194: 309-316.
39. Yoon BH, Romero R, Park JS et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000; 182: 675-681.
40. Salafia CM, Minior VK, Rosenkrantz TS et al. Maternal, placental, and neonatal associations with early germinal matrix/intraventricular hemorrhage in infants born before 32 weeks' gestation. Am J Perinatol 1995; 12: 429-436.
41. Buhimschi IA, Christner R, Buhimschi CS. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. Br J Obstet Gynaecol 2005; 112: 173-181.
42. Gravett MG, Novy MJ, Rosenfeld RG et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 2004; 292: 462-469.
43. Romero R, Espinoza J, Rogers WT et al. Proteomic analysis of amniotic fluid to identify women with preterm labor and intra-amniotic inflammation/infection: the use of a novel computational method to analyze mass spectrometric profiling. J Matern Fetal Neonatal Med 2008; 21: 367-388.
44. Buhimschi IA, Zambrano E, Pettker CM et al. Using proteomic analysis of the human amniotic fluid to identify histologic chorioamnionitis. Obstet Gynecol 2008; 111: 403-412.
45. Buhimschi CS, Bhandari V, Hamar BD et al. Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med 2007; 4: e18.
46. Duff P. Antibiotic selection for infections in obstetric patients. Semin Perinatol 1993; 17: 367-378.
47. Gibbs RS, Dinsmoor MJ, Newton ER, Ramamurthy RS. A randomized trial of intrapartum versus immediate postpartum treatment of women with intra-amniotic infection. Obstet Gynecol 1988; 72: 823-828.
48. Edwards RK, Duff P. Single additional dose postpartum therapy for women with chorioamnionitis. Obstet Gynecol 2003; 102: 957-961.
49. Maberry MC, Gilstrap LC 3rd, Bawdon R, Little BB, Dax J. Anaerobic coverage for intra-amnionic infection: maternal and perinatal impact. Am J Perinatol 1991; 8: 338-341.
50. Rijhsinghani A, Savopoulos SE, Walters JK, Huggins G, Hibbs JR. Ampicillin/sulbactam versus ampicillin alone for cesarean section prophylaxis: a randomized double-blind trial. Am J Perinatol 1995; 12: 322-324.
51. Sperling RS, Ramamurthy RS, Gibbs RS. A comparison of intrapartum versus immediate postpartum treatment of intra-amniotic infection. Obstet Gynecol 1987; 70: 861-865.
52. Lockwood C, Lemons J, eds. Guidelines for perinatal care, 6th edn. Washington D.C.: American Academy of Pediatrics, American College of Obstetricians and Gynecologists, 2007.
53. Chapman SJ, Owen J. Randomized trial of single-dose versus multiple-dose cefotetan for the postpartum treatment of intrapartum chorioamnionitis. Am J Obstet Gynecol 1997; 177: 831-834.
54. Turnquest MA, How HY, Cook CR et al. Chorioamnionitis: is continuation of antibiotic therapy necessary after cesarean section? Am J Obstet Gynecol 1998; 179: 1261-1266.
55. Ward K, Theiler RN. Once-daily dosing of gentamicin in obstetrics and gynecology. Clin Obstet Gynecol 2008; 51: 498-506.
56. Locksmith GJ, Chin A, Vu T, Shattuck KE, Hankins GD. High compared with standard gentamicin dosing for chorioamnionitis: a comparison of maternal and fetal serum drug levels. Obstet Gynecol 2005; 105: 473-479.
57. Lyell DJ, Pullen K, Fuh K et al. Daily compared with 8-hour gentamicin for the treatment of intrapartum chorioamnionitis: a randomized controlled trial. Obstet Gynecol 2010; 115: 344-349.
58. Kirshon B, Moise KJ Jr, Wasserstrum N. Effect of acetaminophen on fetal acid-base balance in chorioamnionitis. J Reprod Med 1989; 34: 955-959.
59. Bader AM, Gilbertson L, Kirz L, Datta S. Regional anesthesia in women with chorioamnionitis. Reg Anesth 1992; 17: 84-86.
60. Goodman EJ, DeHorta E, Taguiam JM. Safety of spinal and epidural anesthesia in parturients with chorioamnionitis. Reg Anesth 1996; 21: 436-441.
61. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE collaborative group. Lancet 2001; 357: 979-988.
62. Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2010; Issue 8: CD001058.
63. Ogasawara KK, Goodwin TM. The efficacy of prophylactic erythromycin in preventing vertical transmission of ureaplasma urealyticum. Am J Perinatol 1997; 14: 233-237.
64. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE collaborative group. Lancet 2001; 357: 989-994.
65. Ovalle A, Romero R, Gomez R et al. Antibiotic administration to patients with preterm labor and intact membranes: is there a beneficial effect in patients with endocervical inflammation? J Matern Fetal Neonatal Med 2006; 19: 453-464.
66. Goldenberg RL, Mwatha A, Read JS et al. The HPTN 024 study: the efficacy of antibiotics to prevent chorioamnionitis and preterm birth. Am J Obstet Gynecol 2006; 194: 650-661.
67. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists, number 72, May 2006: vaginitis. Obstet Gynecol 2006; 107: 1195-1206.
68. Yudin MH, Money DM. Screening and management of bacterial vaginosis in pregnancy. J Obstet Gynaecol Can 2008; 30: 702-716.
69. Rouse DJ, Hauth JC, Andrews WW, Mills BB, Maher JE. Chlorhexidine vaginal irrigation for the prevention of peripartal infection: a placebo-controlled randomized clinical trial. Am J Obstet Gynecol 1997; 176: 617-622.
70. Monahan E, Katz VL, Cox RL. Amnioinfusion for preventing puerperal infection. A prospective study. J Reprod Med 1995; 40: 721-723.
71. Parilla BV, McDermott TM. Prophylactic amnioinfusion in pregnancies complicated by chorioamnionitis: a prospective randomized trial. Am J Perinatol 1998; 15: 649-652.
72. Adair CD, Ernest JM, Sanchez-Ramos L, Burrus DR, Boles ML, Veille JC. Meconium-stained amniotic fluid-associated infectious morbidity: a randomized, double-blind trial of ampicillin-sulbactam prophylaxis. Obstet Gynecol 1996; 88: 216-220.